Abnormal liver tests are not sufficient for diagnosis of hepatic graft‐versus‐host disease in critically ill patients

Alexander H. Yang, Mai Ai Thanda Han, Niharika Samala, Bisharah S. Rizvi, Rachel Marchalik, Ohad Etzion, Elizabeth C. Wright, Ruchi Patel, Vinshi Khan, Devika Kapuria, Vikramaditya Samala Venkat, David E. Kleiner, Christopher Koh, Jennifer A. Kanakry, Christopher G. Kanakry, Steven Pavletic, Kirsten M. Williams, Theo Heller – 8 May 2022 – Hepatic graft‐versus‐host disease (HGVHD) contributes significantly to morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Clinical findings and liver biomarkers are neither sensitive nor specific.

Reply

Cyriac Abby Philips, Ajay Kumar Patwa, Pavan Hanchanale, Chetan Kalal, Saptarshi Bishnu, Mithun Sharma, the Liver Research Club India (LIVERECI) – 8 May 2022

Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018

Emily Truong, Yee Hui Yeo, Galen Cook‐Wiens, Mark Muthiah, Ju Dong Yang, Vinay Sundaram, Devon Chang, Tsuyoshi Todo, Irene K. Kim, Shelly C. Lu, Veronica Wendy Setiawan, Vincent W. S. Wong, Stephen A. Harrison, Naim Alkhouri, Mazen Noureddin – 8 May 2022 – Studies have examined nonalcoholic fatty liver disease (NAFLD) prevalence and severity in Asians; however, this is not well understood in Asian Americans (both East and South Asian Americans) as few studies have analyzed this population.

Subscribe to